Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia.
Christine M McMahonJonathan CanaaniBryan ReaRachel L SargentJulianne N QualtieriChristopher D WattJennifer J D MorrissetteMartin CarrollAlexander E PerlPublished in: Blood advances (2020)